Methods of use of cd24 for the prevention and treatment of leukemia relapse
AssigneesOncoimmune, Inc., University of Maryland, Baltimore
InventorsYang Liu, Pan Zheng, Martin Devenport
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of a CD24 protein for preventing or treating relapse of a cancer in a subject. The present invention also relates to the use of a CD24 protein for reducing cancer stem cell activity.
Claims21
A method of preventing or treating relapse of a cancer in a subject in need thereof, comprising administering a CD24 protein to the subject, wherein the cancer is Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML), Myelodysplastic syndrome (MDS), or Chronic Myelomonocytic Leukemia (CMML).
-5. (canceled)
-46. (canceled)
Dependencies are inferred from the claim text.